Stoke Therapeutics
STOK
STOK
126 hedge funds and large institutions have $422M invested in Stoke Therapeutics in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-4
Holders Change %
-3.08%
% of All Funds
1.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
45
Reduced
30
Closed
27
Calls
$60K
Puts
$973K
Net Calls
-$913K
Net Calls Change
-$688K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$7.85M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3.48M |
| 4 |
CC
Checkpoint Capital
San Francisco,
California
|
+$2.83M |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$2.67M |
Top Sellers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.16M |
| 3 |
Squarepoint
New York
|
-$1.33M |
| 4 |
EAM
Exome Asset Management
New York
|
-$1.25M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.15M |
